Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lunivia 1mg tablets
0401010AEBBAAAA
|
Lunivia | Eszopiclone | Central Nervous System | No data available |
|
Lunivia 2mg tablets
0401010AEBBABAB
|
Lunivia | Eszopiclone | Central Nervous System | No data available |
|
Lunivia 3mg tablets
0401010AEBBACAC
|
Lunivia | Eszopiclone | Central Nervous System | No data available |
|
Lupaxis 100mg prolonged-release tablets
0407020AGBEABAD
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 150mg prolonged-release tablets
0407020AGBEACAE
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 200mg prolonged-release tablets
0407020AGBEADAF
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 250mg prolonged-release tablets
0407020AGBEAEAG
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lupaxis 50mg prolonged-release tablets
0407020AGBEAAAC
|
Lupaxis | Tapentadol | Central Nervous System | No data available |
|
Lysantin 50mg tablets
0409020N0BDAAAM
|
Lysantin | Orphenadrine hydrochloride | Central Nervous System | No data available |
|
Majoven XL 37.5mg capsules
0403040W0CFAAAS
|
Majoven | Venlafaxine | Central Nervous System | No data available |
|
Mandanol 6+ paracetamol 250mg/5ml oral suspension
0407010H0CGADBG
|
Mandanol | Paracetamol | Central Nervous System | No data available |
|
Mandanol Infant paracetamol 120mg/5ml oral suspension
0407010H0CGACAW
|
Mandanol | Paracetamol | Central Nervous System | No data available |
|
Mandanol Plus tablets
0407010U0BEAAAA
|
Mandanol Plus | Paracetamol and caffeine | Central Nervous System | No data available |
|
Maprotiline 10mg tablets
0403010S0AAAAAA
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 25mg tablets
0403010S0AAABAB
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 50mg tablets
0403010S0AAAEAE
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Maprotiline 75mg tablets
0403010S0AAADAD
|
Maprotiline hydrochloride | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Marol 100mg modified-release tablets (Morningside)
040702040BNAAAC
|
Marol | Tramadol hydrochloride | Central Nervous System | No data available |
|
Marol 200mg modified-release tablets (Morningside)
040702040BNACAE
|
Marol | Tramadol hydrochloride | Central Nervous System | No data available |
|
Matever 250mg tablets
0408010A0BCADAA
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Matever 500mg tablets
0408010A0BCACAB
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Matever 500mg/5ml concentrate for inf vials
0408010A0BCAEAJ
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Matever 750mg tablets
0408010A0BCABAI
|
Matever | Levetiracetam | Central Nervous System | No data available |
|
Max Strength Sinus Pressure & Pain Relief Day & Night caps
0407010X0CDANA0
|
Boots (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | No data available |
|
Maximum Strength Aspro Clear 500mg effervescent tablets
0407010B0BGACAG
|
Aspro Clear | Aspirin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.